Risk factors for hypogammaglobulinemia after allo-SCT

被引：20

作者：

Arai, Y. ^{[1
]}

Yamashita, K. ^{[1
]}

Mizugishi, K. ^{[1
]}

Kondo, T. ^{[1
]}

Kitano, T. ^{[1
]}

Hishizawa, M. ^{[1
]}

Kadowaki, N. ^{[1
]}

Takaori-Kondo, A. ^{[1
]}

机构：

[1] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan

来源：

BONE MARROW TRANSPLANTATION | 2014年 / 49卷 / 06期

关键词：

STEM-CELL TRANSPLANTATION; IMMUNOGLOBULIN; SURVIVAL; BLOOD; GVHD;

D O I：

10.1038/bmt.2014.28

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：859 / 861

页数：3

共 11 条

[1] Serum Neutrophil Extracellular Trap Levels Predict Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation [J].

Arai, Yasuyuki ;

Yamashita, Kouhei ;

Mizugishi, Kiyomi ;

Watanabe, Tomohiro ;

Sakamoto, Soichiro ;

Kitano, Toshiyuki ;

Kondo, Tadakazu ;

Kawabata, Hiroshi ;

Kadowaki, Norimitsu ;

Takaori-Kondo, Akifumi .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (12) :1683-1689

[2] A potential role for B cells in suppressed immune responses in cord blood transplant recipients [J].

Beaudette-Zlatanova, B. C. ;

Le, P. T. ;

Knight, K. L. ;

Zhang, S. ;

Zakrzewski, S. ;

Parthasarathy, M. ;

Stiff, P. J. .

BONE MARROW TRANSPLANTATION, 2013, 48 (01) :85-93

[3] Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections [J].

Casulo, Carla ;

Maragulia, Jocelyn ;

Zelenetz, Andrew D. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (02) :106-111

[4] Incidence and risk factors for hypogammaglobulinemia in pediatric patients following allo-SCT [J].

Frangoul, H. ;

Min, E. ;

Wang, W. ;

Chandrasekhar, R. ;

Calder, C. ;

Evans, M. ;

Manes, B. ;

Bruce, K. ;

Brown, V. ;

Ho, R. ;

Domm, J. .

BONE MARROW TRANSPLANTATION, 2013, 48 (11) :1456-1459

[5] Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research [J].

Giralt, Sergio ;

Ballen, Karen ;

Rizzo, Douglas ;

Bacigalupo, Andreas ;

Horowitz, Mary ;

Pasquini, Marcelo ;

Sandmaier, Brenda .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (03) :367-369

[6] Use of immunoglobulins in the prevention of GvHD in a xenogeneic NOD/SCID/γc- mouse model [J].

Gregoire-Gauthier, J. ;

Durrieu, L. ;

Duval, A. ;

Fontaine, F. ;

Dieng, M. M. ;

Bourgey, M. ;

de Serre, N. Patey-Mariaud ;

Louis, I. ;

Haddad, E. .

BONE MARROW TRANSPLANTATION, 2012, 47 (03) :439-450

[7] Use of Matched Unrelated Donors Compared with Matched Related Donors Is Associated with Lower Relapse and Superior Progression-Free Survival after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation [J].

Ho, Vincent T. ;

Kim, Haesook T. ;

Aldridge, Julie ;

Liney, Deborah ;

Kao, Grace ;

Armand, Philippe ;

Koreth, John ;

Cutler, Corey ;

Ritz, Jerome ;

Antin, Joseph H. ;

Soiffer, Robert J. ;

Alyea, Edwin P. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (08) :1196-1204

[8]

Keven K, 2003, Transpl Infect Dis, V5, P181, DOI 10.1111/j.1399-3062.2003.00035.x

[9] Mycophenolate mofetil: fully utilizing its benefits for GvHD prophylaxis [J].

Minagawa, Kentaro ;

Yamamori, Motohiro ;

Katayama, Yoshio ;

Matsui, Toshimitsu .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (01) :10-25

[10] LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE BY THE ADMINISTRATION OF METHOTREXATE AND CYCLOSPORINE IN JAPANESE LEUKEMIA PATIENTS AFTER BONE-MARROW TRANSPLANTATION FROM HUMAN-LEUKOCYTE ANTIGEN COMPATIBLE SIBLINGS - POSSIBLE ROLE OF GENETIC HOMOGENEITYT [J].

MORISHIMA, Y ;

MORISHITA, Y ;

TANIMOTO, M ;

OHNO, R ;

SAITO, H ;

HORIBE, K ;

HAMAJIMA, N ;

NAITO, K ;

YAMADA, K ;

YOKOMAKU, S ;

HIRABAYASHI, N ;

YAMADA, H ;

NAKAIDE, Y ;

KOJIMA, S ;

MINAMI, S ;

MATSUYAMA, K ;

KODERA, Y .

BLOOD, 1989, 74 (06) :2252-2256

← 1 2 →